Search - tctmd.com

Displaying 141 - 160 of 196

Sort: Relevancy | Date

News Conference News WCC 2018

Rising CVD Threatens Middle East and North Africa

Todd Neale

December 13, 2018

News Conference News WCC 2018

Man’s Best Friend, Especially After an MI or Stroke

Todd Neale

December 11, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Yael L. Maxwell

October 30, 2018

News Daily News

Health Forecast for 2040: Improved Life Expectancy for Most, but Troubling Trends Ahead

L.A. McKeown

October 24, 2018

News Daily News

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Yael L. Maxwell

October 23, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Daily News

BMI, Blood Pressure Strongly Linked Across Diverse Subgroups in China

Caitlin E. Cox

August 21, 2018

News Daily News

Chew on This: Review Tackles Controversies in Nutrition for CV Health

Lucy Hicks

July 23, 2018

News Daily News

CVD Prevention and Control Remains a Challenge in India

L.A. McKeown

June 26, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Michael O'Riordan

April 16, 2018

News Daily News

Particulate Matter From California Wildfires Linked to Cardiovascular and Cerebrovascular Events

L.A. McKeown

April 12, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News ACC 2018

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

Caitlin E. Cox

February 28, 2018

Advertisement

Rising CVD Threatens Middle East and North Africa

Man’s Best Friend, Especially After an MI or Stroke

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Health Forecast for 2040: Improved Life Expectancy for Most, but Troubling Trends Ahead

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

BMI, Blood Pressure Strongly Linked Across Diverse Subgroups in China

Chew on This: Review Tackles Controversies in Nutrition for CV Health

CVD Prevention and Control Remains a Challenge in India

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Particulate Matter From California Wildfires Linked to Cardiovascular and Cerebrovascular Events

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content